Full Press Release Details
This agreement grants Vizient clients enhanced access to Natrelle®, the broadest selection of breast implant options on the market.
IRVINE, Calif. , Oct. 1, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), announced today that Natrelle® has been named a supplier by Vizient, Inc., the nation's largest provider-driven healthcare performance improvement company. This agreement connects Natrelle® to Vizient's extensive network of academic medical centers, community hospitals, integrated delivery networks, and non-acute care providers, representing more than half of U.S. healthcare organizations.
Through this contract, Vizient clients will gain enhanced access to Natrelle®'s unmatched offerings, including more than 300 implant options within the most comprehensive breast implant line. Providers will also benefit from competitive pricing, a simplified procurement process, greater operational efficiency, and direct support from the brand's experienced sales and technical teams.
"This agreement with Vizient underscores our commitment to supporting women through their breast reconstruction journeys while equipping providers with the tools they need to deliver exceptional care," said Glen Curran, Senior Vice President, U.S., Allergan Aesthetics. "We're proud to offer Natrelle® to Vizient's clients and support their ongoing efforts in delivering personalized, patient-centered outcomes."
Built on a 50-year legacy of excellence and innovation, Natrelle® is the number one selected breast implant by plastic surgeons 1 *. For more information about Natrelle®, please visit www.natrelle.com .
*Based on surgeon survey data, August 2024 (N=478).
Natrelle ® Breast Implants IMPORTANT SAFETY INFORMATION AND APPROVED USES
Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery.
Breast implants have been associated with the development of a cancer of the immune system called breast implant–associated anaplastic large cell lymphoma (BIA-ALCL). This cancer occurs more commonly in patients with textured breast implants than smooth implants, although rates are not well defined. Some patients have died from BIA-ALCL.
Patients receiving breast implants have reported a variety of systemic symptoms, such as joint pain, muscle aches, confusion, chronic fatigue, autoimmune diseases, and others. Individual patient risk for developing these symptoms has not been well established. Some patients report complete resolution of symptoms when the implants are removed without replacement.
Who can get breast implants? Natrelle ® Breast Implants are approved for the following:
Who should NOT get breast implants? Breast implant surgery should NOT be performed in:
What should I tell my doctor? Tell your doctor if you have any of the following conditions, as the risks of breast implant surgery may be higher:
What else should I consider?
What are key complications with breast implants? Key complications include reoperation, implant removal with or without replacement, implant rupture with silicone-filled implants, implant deflation with saline-filled implants, and capsular contracture (severe scar tissue around the implant). Other complications include breast pain, swelling, asymmetry, wrinkling/rippling, implant malposition nipple complications, hypertrophic scarring, and implant palpability/visibility.
Talk to your doctor about other complications.
For more information, see the patient brochures at www.allergan.com/products . To report a problem with Natrelle ® Breast Implants, please call Allergan ® at 1-800-624-4261. The sale and distribution of Natrelle ® Breast Implants is restricted to licensed physicians who provide information to patients about the risks and benefits of breast implant surgery.
About Natrelle® Natrelle® offers a wide range of breast implant options designed with safety, science, and aesthetics in mind. Backed by over 600 published studies and more than 50 years of research and experience, Natrelle® implants provide patients and surgeons with choices to support personalized outcomes.
About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skincare, and more. With cutting-edge science and a deep understanding of patients, we are committed to empowering confidence.
Allergan Aesthetics Media: Ember Garrett +1 (949) 413-6091 [email protected]
AbbVie Investors: Liz Shea +1 (847) 935-2211 [email protected]